Career history of Sachiyo Minegishi
Former positions of Sachiyo Minegishi
| Companies | Position | Start | End |
|---|---|---|---|
| BLUEBIRD BIO, INC. | Corporate Officer/Principal | 01/04/2016 | 01/09/2020 |
| AEGERION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/09/2012 | 01/04/2016 |
| AKOUOS | Director of Finance/CFO | 01/10/2020 | - |
Training of Sachiyo Minegishi
| Massachusetts Institute of Technology | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Statistics
International
| United States | 6 |
Operational
| Corporate Officer/Principal | 2 |
| Director of Finance/CFO | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 4 |
| Finance | 2 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| BLUEBIRD BIO, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Akouos, Inc.
 Akouos, Inc. BiotechnologyHealth Technology Akouos, Inc. is a precision genetic medicine company, which engages in the development of precision genetic medicines to restore and preserve hearing in genetically-defined patient populations. The firm's lead product candidate, AK-OTOF, is a gene therapy for the treatment of hearing loss due to mutations in the OTOF gene. It develops targeted adeno-associated viral vector based gene therapies for sensorineural hearing loss, which results from dysfunction or damage to sensory cells and nerve fibers of the inner ear. The company was founded by Emmanuel J. Simons, William F. Sewell, Richard H. Smith, Luk H. Vandenberghe, and Michael J. McKenna on March 7, 2016 and is headquartered in Boston, MA. | Health Technology |
Aegerion Pharmaceuticals, Inc.
 Aegerion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aegerion Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development and commercialization of therapies for patients with debilitating rare diseases. The company was founded by David I. Scheer, Gerald L. Wisler and William H. Lewis in 2005 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Sachiyo Minegishi
- Experience